Cholangiocarcinoma and High-Grade Dysplasia in Young Patients with Primary Sclerosing Cholangitis

Digestive Diseases and Sciences

Volumn 59, Issue 9, 2014, Pages 2320-2324

  Liu, Roy ^a   Cox, Kristen ^a   Guthery, Stephen L ^b   Book, Linda ^b   Witt, Benjamin ^b   Chadwick, Barbara ^b   Adler, Douglas G ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cholangiocarcinoma; ERCP; Primary sclerosing cholangitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; CAPECITABINE; CISPLATIN; FLUOROURACIL; GEMCITABINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CASE REPORT; CHOLESTASIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DYSPLASIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATIC DUCT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRANSAMINASEMIA; JAUNDICE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE PULMONARY NODULES; NAUSEA; NAUSEA AND VOMITING; PANCREATICODUODENECTOMY; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; SPLENOMEGALY; ULCERATIVE COLITIS; VOMITING; YOUNG ADULT;

ADOLESCENT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; CROHN DISEASE; FATAL OUTCOME; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84907879387     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3152-0     Document Type: Article

References (23)

1. Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case–control study. Gastroenterology. 2005;128:620–626.
2. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case–control study. Clin Gastroenterol Hepatol. 2007;5:1221–1228.
3. Mangeya N, Mafukidze AT, Pascoe M, et al. Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection. Int J STD AIDS. 2008;19:717–718.
4. Kulkarni PB, Beatty E. Cholangiocarcinoma associated with biliary cirrhosis due to congenital biliary atresia. Am J Dis Child. 1977;131:442–444.
5. Cunningham JJ. Cholangiocarcinoma occurring after childhood radiotherapy for Wilm’s tumor. Hepatogastroenterology. 1990;37:395–397.
6. Bismuth H, Krissat J. Choledochal cystic malignancies. Ann Oncol. 1990;10:94–98.
7. Tanaka S, Kubota M, Yagi M, et al. An 11-year-old male patient demonstrating cholangiocarcinoma associated with congenital biliary dilatation. J Pediatr Surg. 2006;41:e15–e19.
8. Hayward AR, Levy J, Facchetti F, et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol. 1997;158:977–983.
9. Saikusa N, Naito S, Iinuma Y, Ohtani T, Yokoyama N, Nitta K. Invasive cholangiocarcinoma identified in congenital biliary dilatation in a 3-year-old boy. J Pediatr Surg. 2009;44:2202–2205.
10. Bjornsson E, Angulo P. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:1677–1682.
11. Deneau M, Adler DG, Schwartz JJ, et al. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;52:617–620.
12. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–615.
13. Tischendorf JJ, Hecker H, Kruger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol. 2007;102:107–114.
14. Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case–control study. Hepatology. 1998;27:311–316.
15. de Groen PC. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology. 2000;31:247–248.
16. Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213:21–25.
17. Suarez-Munoz MA, Fernandez-Aguilar JL, Sanchez-Perez B, et al. Risk factors and classifications of hilar cholangiocarcinoma. World J Gastrointest Oncol. 2013;5:132–138.
18. Awadallah NS, Chen YK, Piraka C, Antillon MR, Shah RJ. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am J Gastroenterol. 2006;101:284–291.
19. Moreno Luna LE, Kipp B, et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology. 2006;131:1064–1072.
20. Barr Fritcher EG, Kipp BR, Voss JS, et al. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol. 2011;106:2023–2028.
21. Belchacz BG. Tumors of the bile ducts, gallbladder, and ampulla. In: Feldman M, ed. Sleisenger and Fortran’s Gastrointestinal and Liver Disease, vol. 1. 9th ed. Philadelphia: Saunders; 2010:1171–1176.
22. Barr Fritcher EG, Voss JS, Jenkins SM, et al. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy. Cancer Cytopathol. 2013. Epub. 02/01/2014.
23. Vasilieva LE, Papadhimitriou SI, Alexopoulou A, et al. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations. Hum Pathol. 2013;44:2173–2179. doi:10.1016/j.humpath.2013.04.012.